Clinical Trial: Repurposing alpha1 Noradrenergic Antagonists for Alcoholism Treatment

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Repurposing alpha1 Noradrenergic Antagonists for Alcoholism Treatment

Brief Summary: Double-blind, placebo-controlled, cross-over design study examining the effects of a norepinephrine alpha1 receptor antagonist (prazosin) on stress reactivity in a laboratory stressor task.